{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:33Z","timestamp":1772166153623,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Mol Allergy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary Systemic Sclerosis (PSS) is a connective tissue disorder characterized by excessive collagen deposition in the skin and internal organs. Interstitial lung disease (ILD) is a late demonstration of PSS and cytokines can contribute to the disease pathology.\u00a0The purpose of the current study was to determine the association between serum interleukin-6 level\u00a0and pulmonary involvement in progressive systemic sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and materials<\/jats:title>\n                    <jats:p>Demographic data and serum interleukin-6 levels were measured for 30 PSS patients with pulmonary involvement (case group) and 30 PSS patients without pulmonary involvement (control group) following informed consent. The disease duration and activity, C-reactive protein (CRP), chest x-ray and highresolution CT scan (HRCT) findings, ejection fraction (EF) and echocardiography findings, and pulmonary artery pressure (PAP) were also determined in both groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The age of patients in case and control groups was 52.5\u2009\u00b1\u20099.3 and 43.9\u2009\u00b1\u20099.7\u00a0years, respectively (p\u2009=\u20090.001). No significant difference was found between serum levels of IL-6 in case and control groups (73.1\u2009\u00b1\u200995.4 vs 46.7\u2009\u00b1\u200983.6\u00a0pg\/ml, p\u2009=\u20090.267). However, IL-6 level was significantly higher in male case patients compared to male controls (p\u2009=\u20090.007). The duration of PSS was 11.6\u2009\u00b1\u20096.4 and 7.4\u2009\u00b1\u20094.2\u00a0years in case and control groups, respectively (p\u2009=\u20090.002). The quantitative CRP and PAP was also significantly higher in case patients (p\u2009=\u20090.01 and p\u2009&lt;\u20090.001, respectively). There was found reticulonodular pattern in 20 (66.7%) of the cases, whereas 28 (93.3%) of the controls had normal Chest X-rays (CXR) (p\u2009&lt;\u20090.001). EF was significantly lower in case patients compared to control patients (p\u2009=\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The serum level of IL-6 did not appear to have a relationship with pulmonary involvement, hence it could not be regarded as a potential therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12948-023-00188-1","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T01:01:26Z","timestamp":1693875686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum interleukin-6 level and its association with pulmonary involvement in progressive systemic sclerosis; a case-control study\u00a0"],"prefix":"10.1186","volume":"21","author":[{"given":"Ahmad","family":"Piroozmand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batool","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Haddad Kashani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Amini Mahabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"3","key":"188_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","volume":"176","author":"H Schurawitzki","year":"1990","unstructured":"Schurawitzki H, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990;176(3):755\u20139.","journal-title":"Radiology"},{"key":"188_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(66)90030-0","author":"F Bianchi","year":"1966","unstructured":"Bianchi F, et al. Analysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literature. J Clin Epidemiol. 1966. https:\/\/doi.org\/10.1016\/0021-9681(66)90030-0.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"188_CR3","first-page":"523","volume":"18","author":"A Piroozmand","year":"2017","unstructured":"Piroozmand A, Kashani HH, Zamani B. Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev APJCP. 2017;18(2):523.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"11","key":"188_CR4","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"188_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Investig. 2007;117(3):557\u201367.","journal-title":"J Clin Investig"},{"key":"188_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/721608","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Anderson ME, Moots RJ. The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol. 2011. https:\/\/doi.org\/10.1155\/2011\/721608.","journal-title":"Int J Rheumatol"},{"issue":"2","key":"188_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001;27(2):140\u20136.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"188_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","volume":"138","author":"E Scala","year":"2004","unstructured":"Scala E, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol. 2004;138(3):540\u20136.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"188_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2010.133587","volume":"70","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, et al. Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis. 2011;70(2):366\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"188_CR10","first-page":"11","volume":"15","author":"HH Kashani","year":"2013","unstructured":"Kashani HH, et al. Expression of galectin-3 as a testis inflammatory marker in vasectomised mice. Cell J. 2013;15(1):11.","journal-title":"Cell J"},{"issue":"1","key":"188_CR11","first-page":"65","volume":"11","author":"H Nikzad","year":"2013","unstructured":"Nikzad H, et al. Expression of galectin-8 on human endometrium: molecular and cellular aspects. Iran J Reprod Med. 2013;11(1):65.","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"188_CR12","first-page":"185","volume":"8","author":"MR Sharif","year":"2016","unstructured":"Sharif MR, et al. The relationship between iron deficiency and febrile convulsion: a case-control study. Global J Health Sci. 2016;8(2):185.","journal-title":"Global J Health Sci"},{"key":"188_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fcimb.2017.00290","volume":"7","author":"H Haddad Kashani","year":"2017","unstructured":"Haddad Kashani H, et al. A novel chimeric endolysin with antibacterial activity against methicillin-resistant staphylococcus aureus. Front Cell Infect Microbiol. 2017;7:290.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"188_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5539\/gjhs.v8n1p249","volume":"8","author":"A Lotfi","year":"2016","unstructured":"Lotfi A, et al. Comparing the effects of two feeding methods on metabolic bone disease in newborns with very low birth weights. Global J Health Sci. 2016;8(1):249.","journal-title":"Global J Health Sci"},{"issue":"1","key":"188_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12602-016-9207-0","volume":"8","author":"HK Jalali","year":"2016","unstructured":"Jalali HK, et al. Antagonistic activity of Nocardia brasiliensis PTCC 1422 against isolated enterobacteriaceae from urinary tract infections. Probiotics Antimicrob Proteins. 2016;8(1):41\u20135.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"7","key":"188_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4314\/tjpr.v14i7.5","volume":"14","author":"M Ferdosian","year":"2015","unstructured":"Ferdosian M, et al. Identification of immunotopes against mycobacterium leprae as immune targets using PhDTm-12mer phage display peptide library. Trop J Pharm Res. 2015;14(7):1153\u20139.","journal-title":"Trop J Pharm Res"},{"issue":"4","key":"188_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.phrp.2016.06.004","volume":"7","author":"R Dehghani","year":"2016","unstructured":"Dehghani R, et al. Factors influencing animal bites in Iran: a descriptive study. Osong Public Health Res Perspect. 2016;7(4):273\u20137.","journal-title":"Osong Public Health Res Perspect"},{"issue":"4","key":"188_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12602-016-9221-2","volume":"8","author":"MR Sharif","year":"2016","unstructured":"Sharif MR, et al. The effect of a yeast probiotic on acute diarrhea in children. Probiotics Antimicrob Proteins. 2016;8(4):211\u20134.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"188_CR19","unstructured":"Kashani HH, et al. Synergism effect of nisin peptide in reducing chemical preservatives in food industry. Life Science Journal, 2012. 9(1)."},{"issue":"3","key":"188_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.21037\/jgo.2019.01.09","volume":"10","author":"R Gosain","year":"2019","unstructured":"Gosain R, et al. Interleukin-6 as a biomarker in patients with hepatobiliary cancers. J Gastrointest Oncol. 2019;10(3):537\u201345.","journal-title":"J Gastrointest Oncol"},{"issue":"5834","key":"188_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u20134.","journal-title":"Science"},{"issue":"7","key":"188_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.autrev.2015.02.002","volume":"14","author":"M Iudici","year":"2015","unstructured":"Iudici M, et al. Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? Autoimmun Rev. 2015;14(7):575\u20138.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"188_CR23","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/rheumatology\/ket131","volume":"52","author":"Z Jurisic","year":"2013","unstructured":"Jurisic Z, et al. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis. Rheumatology. 2013;52(7):1298\u2013302.","journal-title":"Rheumatology"},{"key":"188_CR24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120725","author":"A De Lauretis","year":"2013","unstructured":"De Lauretis A, et al. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. J Rheumatol. 2013. https:\/\/doi.org\/10.3899\/jrheum.120725.","journal-title":"J Rheumatol"},{"issue":"4","key":"188_CR25","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/ar2766","volume":"11","author":"K Schmidt","year":"2009","unstructured":"Schmidt K, et al. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther. 2009;11(4):R111.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"188_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1346-8138.1996.tb02680.x","volume":"23","author":"K Nishioka","year":"1996","unstructured":"Nishioka K, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). J Dermatol. 1996;23(10):677\u201382.","journal-title":"J Dermatol"},{"issue":"5","key":"188_CR27","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1164\/ajrccm.149.5.8173768","volume":"149","author":"B Crestani","year":"1994","unstructured":"Crestani B, et al. Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement. Am J Respir Crit Care Med. 1994;149(5):1260\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"188_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejcdt.2014.10.004","volume":"64","author":"M Yousif","year":"2015","unstructured":"Yousif M, et al. Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement. Egypt J Chest Dis Tuberc. 2015;64(1):237\u201341.","journal-title":"Egypt J Chest Dis Tuberc"}],"container-title":["Clinical and Molecular Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12948-023-00188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12948-023-00188-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12948-023-00188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T17:07:36Z","timestamp":1700327256000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalmolecularallergy.biomedcentral.com\/articles\/10.1186\/s12948-023-00188-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/s12948-023-00188-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1785134\/v1","asserted-by":"object"}]},"ISSN":["1476-7961"],"issn-type":[{"value":"1476-7961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study involving human were in accordance with the 1964 Helsinki declaration and ethical standards of the institutional and national research committee of Kashan University of Medical Sciences. The protocol was approved by the research committee of Kashan University of Medical Sciences, Kashan, Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}